Skip to content
Sermo
  • Newsroom
    • News Articles
    • Press Releases
    • Barometer Releases
    • Methodology
  • About
    • Member Reviews
    • Medical Advisory Board
    • Content Reviewers
    • Careers
    • Health Equity at Sermo
    • Patient Stories
  • Member Benefits
    • Earn
    • Socialize
    • Solve
    • Lead
    • Specialize
    • Grow
    • Rate
    • Call
  • Drug Ratings
  • Blog
  • Physician Resources
    • Physician’s guide to surveys
    • Guide to side gigs for physicians
    • How to maximize your survey earnings
    • Guide to AI in healthcare
    • Guide to telehealth for physicians
    • All physician resource articles
  • Log in
  • Sign up
FiercePharma

HCPs say pharmas’ direct drug sale platforms have ‘mixed’ impact on GLP-1 access, care

January 5, 2026 | Updated January 27, 2026

View article

Facebook LinkedIn X

Get The Sermo Roundup

Tap into peer-driven insights, stay informed on the latest challenges in medicine, and explore real-world knowledge shared by fellow doctors.

Sermo

Sermo

  • About
  • Careers
  • Newsroom
  • Health Equity at Sermo
  • Member Reviews
  • Contact Us

Business

  • Physician Insights
  • Physician Engagement
  • Quality Guaranteed
  • Partnerships & Affiliates
  • Medical Market Research Surveys

Resources

  • Support
  • Blog
  • Physician Resources
  • Webinars
  • Sermo vs. Doximity
  • Sermo vs. M3
  • Barometer Data
  • Barometer Reports
  • HCP Sentiment Studies

Quality & Compliance

  • Privacy Policy
  • Terms of Service
  • Code of Conduct
  • Privacy Inquiries
  • Do Not Sell/Share My Info
Copyright © 2026 Sermo

Follow Sermo

  • Facebook
  • X
  • Linkedin